Peripheral MDSCs suppress antigen-specific CD8+ T cells in peripheral blood, while MDSCs from the TME suppress antigen-specific immune response in tumor mass They are also involved in the T cell function modulation, and their number strictly correlates with the risk of recurrence [176]. This evidence concerns the gene CD8A and neoplasm.